Biography Born 3 February 1805 in the Hungerford almshouse in Wiltshire, England 1824 – Medical degree from the University of Edinburgh 1833 – Physician at St. George’s University, London 1835 – Fellow of the Royal Society 1840 – Fellow of…
Vancouver POCUS review of ocular POCUS including lens dislocation, globe rupture, posterior vitreous detachment and retinal detachment by Dr Justin Ahn
The ANZCEN Clinician Educator Incubator will launch in April 2020. If this is your thing, you need to get your EOI in by February 15th 2020!
Maurice Lev (1908 – 1994) was an American cardiologist. Eponymously affiliated with Lenègre-Lev disease disease described in 1964
Ludwig Georg Courvoisier (1843 - 1918) was a Swiss surgeon. Courvoisier Sign (1890)
Unicondylar coronal fracture of the lateral femoral condyle. Rare intra-articular distal femur injury. Axial compression to the knee with transmission of the ground reaction force through the tibial plateau to the femoral condyles.
Biography Born 1879 Died 1943 Medical Eponyms Buerger disease (1908) Carl Friedländer (1847-1887) Felix von Winiwarter (1852-1931) Buerger test Buerger dystoscope Key Medical Contributions Major Publications Controversies References Biography Birch CA. Buerger’s disease. Leo Buerger (1879-1943). Practitioner. 1973;211(266):823-824. Kaplan GW. Leo…
vanPOCUS introduction to point of care ultrasound physics and knobology by Dr. Dan Kim.
Biography Born 1797 Died 1856 Medical Eponyms Gerdy tubercle is the prominence on the lateral side of the proximal tibia where the iliotibial band (ITB) and tibialis anterior muscle attach Gerdy’s Safe Zone () Major Publications Gerdy P-N. Essai de…
Eosinophilic granulomatosis with polyangiitis (EGPA) - archaic eponym: Churg–Strauss syndrome (CSS) or allergic granulomatosis
Alexander Monro secundus (1733-1817) was a Scottish physician and anatomist. Most notable contributions include works on the lymphatic system, the interventricular foramen (of Monro), and the Monro-Kellie doctrine
A fascinating talk by Jack Iwashyna (@iwashyna) on the 'heterogeneity of treatment' effect, what this means for the conduct of randomised control trials and how we should interpret them.